Chirality and its implications in transdermal drug development

Critical Reviews in Therapeutic Drug Carrier Systems

Volumn 17, Issue 4, 2000, Pages 285-325

  Reddy, Indra K ^a   Kommuru, Thirumala R ^b   Zaghloul, Abdel Azim A ^a   Khan, Mansoor A ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b Eurand Inc   (United States)

Author keywords

Chirality; Enantioselective skin permeation; Penetration enhancers; Stereoselectivity; Terpenes; Transdermal drug delivery

Indexed keywords

CARVACROL; DEXTROPROPOXYPHENE; DIGITOXIN; EPHEDRINE; FLECAINIDE; GENACONAZOLE; GLYCERALDEHYDE; KETAMINE; KETOPROFEN; KETOROLAC; LEVAMISOLE; LIMONENE; LINALOOL; MENTHOL; METHYLDOPA; METOPROLOL; MORPHINE; NILVADIPINE; POBILUKAST; PROMETHAZINE; PROPRANOLOL; PSEUDOEPHEDRINE; PYRENE DERIVATIVE; QUINIDINE; QUININE; SOTALOL; TERPENE; UNINDEXED DRUG; VERAPAMIL; WARFARIN;

ANIMAL TISSUE; CHIRALITY; CRYSTAL STRUCTURE; DRUG ACTIVITY; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG DIFFUSION; DRUG LEGISLATION; DRUG PENETRATION; FOOD AND DRUG ADMINISTRATION; HUMAN; HUMAN TISSUE; MEMBRANE STRUCTURE; NONHUMAN; RACEMIC MIXTURE; RAT; REVIEW; SKIN PERMEABILITY; STEREOCHEMISTRY; STRATUM CORNEUM; STRUCTURE ACTIVITY RELATION; THERMODYNAMICS; TRANSDERMAL PATCH;

EID: 0033900193     PISSN: 07434863     EISSN: None     Source Type: Journal    
DOI: 10.1615/critrevtherdrugcarriersyst.v17.i4.10     Document Type: Review

References (119)

1. Chirality in new drug development - Clinical pharmacokinetic considerations
2. A sequential scenerio for the origin of biological chirality
3. Remarks on origins of biomolecular asymmetry
4. Chirality: Implications on drug actions
5. Implications of chirality and geometric isomerism in some psychoactive drugs and their metabolites
6. Drug chirality and its clinical significance
7. Effect of chirality on pharmacokinetics and pharmacodynamics
8. Stereochemical aspects of pharmacotherapy
9. Importance of stereospecific bioanalytical monitoring in drug development
10. Relationship between physical properties and crystal structures of chiral drugs
11. Commonly used chiral drugs: A survey
12. Racemic therapeutics-ethical and regulatory aspects
13. Stereochemistry and bioequivalence
14. The cost benefit ratio of enantiomeric drugs
15. Stereochemistry, a basis for sophisticated nonsense in pharmacokinetics and clinical pharmacology
16. The pharmacological and toxicological significance of the stereochemistry of drug disposition
17. Stereochemical terms and concepts: An overview
18. Fisher Convention
19. Specifications of molecular chirality
20. The biology of the stratum corneum
21. The permeability of mammalian skin to ions
22. Studies of the chemical composition of the horny layer lipids
23. Synthesis and composition of surface lipids of human skin
24. Horny layer lipids. II. Future studies on the overall chemical composition of lipids from normal and pathological human stratum corneum
25. Lipids, membranes, and the human epidermis
26. The biomechanical properties of skin
27. Measurement of transepidermal water loss by electrical hygrometry: Instrumentation and responses to physical and chemical insults
28. The cornified envelope of terminally differentiated human epidermal keratinocytes consists of cross-linked protein
29. Intercellular space in normal human stratum corneum
30. The fine structure of α-keratin
31. Permeability of the skin
32. Therapeutics: Percutaneous absorption, a critical and historical review
33. Essentials of Human Anatomy
34. Permeability of the skin: A review of major concepts
35. Cutaneous and transdermal delivery: Processes and systems of delivery
36. Does solute stereochemsitry influence percutaneous penetration?
37. Unique side-chain conformations encoding for chirality and azimuthal orientation in the molecular packing of skin collagen
38. Enantiospecificity in allergic contact dermatitis
39. Allergic contact dermatitis to tulips: An example of enantiospecificity
40. Comparative studies of the metabolic activation of chrysene in rodent and human skin
41. High stereoselectivity in mouse skin metabolic activation of methylchrysenes to tumorigenic dihydrodiols
42. Marked differences in the tumor-intiating activity of optically pure (+)- and (-)-trans-7,8-dihydroxy-7,8-dihydrobenzo(a)pyrene on mouse skin
43. Stereoselective reversal of MPTP-induced parkinsonism in the marmoset after dermal application of N-0437
44. Optical isomers of leukotriene B4 antagonist have differential effects on granulocyte diapedesis in the guinea pig dermis
45. Enantiomeric difference in percutaneous penetration of propranolol through rat excised skin
46. Studies on percutaneous absorption of drugs,3. Percutaneous absorption of drugs through damaged skin
47. In vitro skin penetration of propranolol enantiomers
48. Effect of chiral enhancers on the permeability of optically active and racemic metoprolol across hairless mouse skin
49. Racemate and enantiomers of ketoprofen: Phase diagram, thermodynamic studies, skin permeability, and use of chiral permeation enhancers
50. Analysis of skin penetration enhancing effect: Of drugs by ethanol-water mixed systems with hyrodynamic pore theory
51. Chemical structure and skin penetrating capacity of a short series of organic phosphates and phosphoric acid
52. Chiral B-blockers for transdermal delivery
53. Stereoselective adsorption and trans-membrane transfer of propranolol enantiomers using cellulose derivatives
54. Effect of menthol on permeability of optically active and racemic propranolol across guinea pig skin
55. Evaluation of stereoselective transdermal transport and concurrent cutaneous hydrolysis of several ester prodrugs of propranolol: Mechanism of stereoselective permeation
56. Permeability of pure enantiomers of ketorolac through human cadaver skin
57. Chiral discrimination in crystalline enantiomer systems: Facts, interpretations, and speculations
58. Binary mixtures of enantiomers
59. Study of mixtures of optical antipodes-XII
60. Ibuprofen racemate and enantiomers: Phase diagram, solubility and thermodynamic studies
61. Chiral discrimination in crystalline enantiomer systems: Facts, interpretations, and speculations
62. The biological properties of the optical isomers of propranolol and their effects on cardiac arrhythmias
63. Clinical and chemical studies with a-methyldopa in patients with hypertension
64. Studies on the optical enantiomorphs of warfarin in man
65. The effect of dextro-, levo-, and racemic verapamil on atrioventricular conduction in humans
66. Polymorphic drug oxidation in humans
67. Clinical pharmacokinetics of ketoprofen and its enantiomers
68. Relationship among physicochemical properties, skin permeability, and topical activity of the racemic compound and pure enantiomers of a new antifungal
69. Transdermal permeation of chiral compounds
70. Stereoselectivity in cutaneous hydrolysis and transdermal transport of propranolol prodrug
71. Species differences in stereoselective hydrolase activity in intestinal mucosa
72. Stereoselective hydrolysis of xenobiotics esters by different cell lines from rat liver and hepatoma and its application to chiral prodrugs for designated growth suppression of cancer cells
73. Synthesis, stereoselective enzymatic hydrolysis, and skin permeation of diastereomeric propranolol ester prodrugs
74. Novel approaches to prodrugs of anticancer diaminodichloroplatinum(II) complexes activated by stereoselective enzymatic ester hydrolysis
75. Absorption and metabolism of topically applied testosterone in an organotypic skin culture
76. Evaluation of Testskin as a model membrane
77. Differential permeation of propranolol enantiomers across human skin in vitro from formulations containing an enantioselective excipient
78. Enhanced skin permeability for transdermal drug delivery: Physiopathological and physicochemical considerations
79. Melting point phase diagrams of free base and hydrochloride salts of bevantolol, pindolol and propranolol
80. Testosterone skin permeation enhancement by menthol through formation of eutectic with drug and interaction with skin lipids
81. Effect of l-menthol on the permeation of indomethacin, mannitol, and cortisone through excised hairless mouse skin
82. Analysis of the combined effect of l-menthol and ethanol as skin permeation enhancers based on a two-layer skin model
83. Effect of menthol and related terpenes on the percutaneous absorption of propranolol across excised hairless mouse skin
84. Transdermal delivery from eutectic systems: Enhanced permeation of a model drug, ibuprofen
85. Influence of composition of l-menthol-ethanol-water ternary solvent system on the transdermal delivery of morphine hydrochloride
86. Effect of pretreatment of skin with cyclic monoterpenes on permeation of diclofenac in hairless rat
87. Skin absorption enhancers
88. Sesquiterpene components of volatile oils as skin penetration enhancers for the hydrophilic permeant 5-fluorouracil
89. Effect of limonene and related compounds on the percutaneous absorption of Indomethacin
90. Percutaneous absorption enhancing effect and skin irritation of monocyclic monoterpenes
91. Chirality and its importance in drug development
92. Chirality and its importance in drug development: What are the issues?
93. Chirality and future drug design
94. Stereoselectivity in clinical pharmacokinetics and drug development
95. The use of stereochemically pure chemicals: A regulatory point of view
96. The efficacy and toxicity of drug stereoisomers
97. Flecainide enantiomers: Disposition in human subjects and electrophysiologic actions in vitro
98. Comparative pharmacokinetics of coumarin anticoagulares XXXVI: Predicted steady-state patters of prothrombin complex activity produced by equieffective doses of R-(+)- and S(-)-warfarin in humans
99. Coronary vasodilator and cardiac effects of optical isomers of verapamil in the dog
100. Stereochemically pure drugs: An industrial perspective
101. Concentration-dependent stereoselective inhibition of the endotoxin-induced hemoconcentration in conscious rats with peptidoleukotriene receptor antagonist SK and F 104353
102. Pharmacodynamic and pharmacokinetic differences between drug enantiomers in humans: An overview
103. Clinical pharmacology of the enantiomers and (-)-p-hydroxy metabolites of indacrinone
104. Hemodynamic and electrophysiologic effects of disopyramide enantiomers in a canine blood superfusion model
105. Observations on the differential metabolism and biological activity of the optical isomers of cyclophosphamide
106. Pharmacology of ketamine isomers in surgical patients
107. Pharmacodynamic modeling of the EEG effects of ketamine and its enantiomers in man
108. The FDA perspective on the development of stereoisomers
109. Current regulatory (draft) guidance on chiral medicinal products: Canada, EEC, Japan, United States